Effectiveness and Safety of Roxadustat for Renal Anemia in Dialysis-dependent Chronic Kidney Disease: a Meta-analysis

Background As the most common clinical manifestation and a major complication in chronic kidney disease, anemia affects the patients' quality of life, increases the risk of renal disease progression and death. Hence, it is important to improve anemia, and monitor and evaluate drug efficacy...

Full description

Bibliographic Details

Published in:	Zhongguo quanke yixue
Main Author:	LI Jiaqing, YANG Qing, YUAN Dunlu, HUANG Jingjing, CHANG Qing, NIE Jingwen, ZHOU Zhu, LI Qing
Format:	Article
Language:	Chinese
Published:	Chinese General Practice Publishing House Co., Ltd 2023-02-01
Subjects:	hemodialysis|roxadustat|hypoxia-inducible factor-prolyl hydroxylase inhibitor|erythropoiesisstimulating agents|renal anemia|effectiveness and safety|systematic review|meta-analysis
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/zx20220581.pdf